ACADIA Pharmaceuticals Inc. (ACAD) Q1 2026 Earnings Call Transcript
ACADIA Pharmaceuticals Inc. (ACAD) Q1 2026 Earnings Call Transcript
seekingalpha.com

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2023 | $3.3B $2.6B–$3.9B | — | $4.33 | — | ±20% | High8 |
FY2024 | $3.6B $3.6B–$3.6B | ▲ +9.5% | $7.40 | ▲ +70.8% | ±1% | Moderate4 |
FY2025 | $3.8B $3.8B–$3.8B | ▲ +5.7% | $8.28 | ▲ +11.9% | ±1% | Moderate4 |
Dividend per payment — last 8 periods
ACADIA Pharmaceuticals Inc. (ACAD) Q1 2026 Earnings Call Transcript

No company information available